Skip to main content
SpringerLink
Log in

Editorial: Building Evidence to Manage Newborn Jaundice Worldwide

  • Commentary
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Subcommittee on Hyperbilirubinemia, American Academy of Pediatrics. Clinical Practice Guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.

    Google Scholar 

  2. Bhutani VK, Vilms RJ, Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol. 2010;30:S6–15.

    Google Scholar 

  3. Cline BK, Vilms V, McGraw K, Donaldson KM, Bhutani VK. Global Burden and Unmet Need for Hyperbilirubinemia Treatment. Pediatric Academic Societies 2011. Abstract #4503.92

  4. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications. Pediatrics. 2009;124:1193–8.

    Article  PubMed  Google Scholar 

  5. Johnson L, Bhutani VK. The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Perinatol. 2011;35:101–13.

    Article  PubMed  Google Scholar 

  6. Arun Babu T, Bhat BV, Joseph NM. Association between peak serum bilirubin and neurodevelopmental outcomes in term babies with hyperbilirubinemia. Indian J Pediatr. 2011; doi:10.1007/s12098-011-0501-2

  7. Chawla D, Jain S, Dhir S, Rani S. Risk assessment strategy for prediction of pathological hyperbilirubinemia in neonates. Indian J Pediatr. 2011; doi:10.1007/s12098-011-0409-x

  8. Maisles MJ. Neonatal jaundice.In: Sinclair JC, Bracken MB eds. Effective care of the newborn infant .Oxford University Press. ISBN: 0-19-261737-0. 1992. pp. 507–61.

  9. Fallah R, Islami Z, Lotfi SR. Single dose of 50mg/kg clofibrate in jaundice of healthy term neonates : Randomized clinical trial of efficacy and safety. Indian J Pediatr. 2011; doi:10.1007/s12098-011-0531-9

  10. Silverman WA. The windermere lecture 1994. The line between ‘knowing’ and ‘doing’: medicine’s dilemma at the end of the twentieth century. Arch Dis Child. 1994;71:261–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Role of Funding Source

Supported in part by Division of Neonatal-Developmental Medicine, Stanford University, CA

Author information

Authors and Affiliations

  1. Division of Neonatal-Perinatal-Developmental Medicine, Department of Pediatrics, Lucile Packard Children’s Hospital, Stanford University School of Medicine, 750 Welch Ave, #315, Palo Alto, CA, 94304, USA

    Vinod K. Bhutani

Authors
  1. Vinod K. Bhutani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vinod K. Bhutani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhutani, V.K. Editorial: Building Evidence to Manage Newborn Jaundice Worldwide. Indian J Pediatr 79, 253–255 (2012). https://doi.org/10.1007/s12098-011-0631-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-011-0631-6

Keywords

Search

Navigation